Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xalacom vs Cosopt in Open-Angle Glaucoma or Ocular Hypertension
NCT00140049Phase 4Completed
- Sponsor
- Viatris
- Start
- Jul 2005
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
Phase 4, randomised, single-blind trial of latanoprost and timolol in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Viatris. Primary endpoint: Mean Intraocular Pressure at 12 weeks. Started Jul 2005; status: completed.
02
Drugs
latanoprosttimolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00140049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140049.